VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 96 filers reported holding VERVE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,579,213 | -25.5% | 2,532,369 | +5.4% | 0.09% | -20.5% |
| Q2 2023 | $45,049,500 | +30.0% | 2,402,640 | 0.0% | 0.11% | +28.7% |
| Q1 2023 | $34,646,069 | -13.8% | 2,402,640 | +15.6% | 0.09% | -21.6% |
| Q4 2022 | $40,214,892 | -33.1% | 2,078,289 | +18.8% | 0.11% | -36.9% |
| Q3 2022 | $60,103,000 | +258.3% | 1,749,737 | +59.4% | 0.18% | +282.6% |
| Q2 2022 | $16,775,000 | +3.5% | 1,097,837 | +54.6% | 0.05% | +24.3% |
| Q1 2022 | $16,208,000 | +18.8% | 710,237 | +92.0% | 0.04% | +48.0% |
| Q4 2021 | $13,642,000 | -21.6% | 370,000 | 0.0% | 0.02% | -24.2% |
| Q3 2021 | $17,390,000 | -22.0% | 370,000 | 0.0% | 0.03% | -21.4% |
| Q2 2021 | $22,293,000 | – | 370,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $515,778,000 | 12.24% |
| Casdin Capital, LLC | 3,038,167 | $142,794,000 | 3.55% |
| Redmile Group, LLC | 1,869,030 | $87,844,000 | 1.53% |
| Logos Global Management LP | 443,265 | $20,833,000 | 1.50% |
| Novo Holdings A/S | 600,000 | $28,200,000 | 1.46% |
| Cormorant Asset Management, LP | 709,224 | $32,667,000 | 1.33% |
| Rock Springs Capital Management LP | 962,826 | $45,253,000 | 0.95% |
| HighVista Strategies LLC | 18,782 | $883,000 | 0.58% |
| RA Capital Management | 880,284 | $41,373,000 | 0.57% |
| Nicholas Investment Partners, LP | 132,300 | $6,218,000 | 0.45% |